New Alzheimer's Drug: U-M Neurologist Can Discuss
July 08, 2023
July 08, 2023
ANN ARBOR, Michigan, July 8 (TNSres) -- The University of Michigan issued the following news release:
* * *
EXPERT ADVISORY
The U.S. Food and Drug Administration has granted full approval to the new Alzheimer's disease drug lecanemab (brand name Leqembi). The medication was granted accelerated approval in January.
Judith Heidebrink, neurologist and clinical core co-lead of the Michigan Alzheimer's Disease Center at the University of Michigan He . . .
* * *
EXPERT ADVISORY
The U.S. Food and Drug Administration has granted full approval to the new Alzheimer's disease drug lecanemab (brand name Leqembi). The medication was granted accelerated approval in January.
Judith Heidebrink, neurologist and clinical core co-lead of the Michigan Alzheimer's Disease Center at the University of Michigan He . . .